Table 3.
Multivariate analysis of factors predicting disease-free survival in adjuvant chemotherapy with platinum-based agent
| Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|
| HR | 95%CI | P value | HR | 95%CI | P value | |
| P value | ||||||
| Gender | ||||||
| Male/female | 1.25 | 0.49-3.18 | 0.639 | 2.11 | 0.77-5.82 | 0.149 |
| Histology | ||||||
| non-SQ/SQ | 1.89 | 0.56-6.37 | 0.303 | 2.38 | 0.65-8.74 | 0.191 |
| Pathological T factor | ||||||
| T3-4/T1-2 | 1.81 | 0.79-4.13 | 0.160 | 1.89 | 0.70-5.11 | 0.208 |
| Pathological N factor | ||||||
| Positive/negative | 3.63 | 1.34-9.85 | 0.011 | 3.15 | 1.12-8.85 | 0.030 |
| Pleural invasion | ||||||
| p1-3/p0 | 1.13 | 0.77-1.67 | 0.533 | 0.82 | 0.50-1.36 | 0.453 |
| Vascular invasion | ||||||
| Positive/negative | 2.25 | 0.93-5.52 | 0.072 | 3.79 | 1.26-11.35 | 0.017 |
| Cox-2 expression | ||||||
| Positive/negative | 3.14 | 1.16-8.49 | 0.024 | 3.96 | 1.38-11.38 | 0.011 |
P value was calculated by log-rank test. HR: hazard ratio; 95%CI: 95% confidence interval; SQ: squamous cell carcinoma; Cox-2: cyclooxygenase-2.